MRL/lpr CD4−CD8− and CD8+ T cells, respectively, mediate Fas‐dependent and perforin cytotoxic pathways
- 1 February 1997
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 27 (2), 415-420
- https://doi.org/10.1002/eji.1830270211
Abstract
Autoimmune-prone MRL/lpr mice, homozygous for the lpr mutation, exhibit defective apoptosis and develop generalized lymphoproliferation with the accumulation of a double-negative (DN: CD4−CD8−) T cell population. The capacity of lpr T lymphocytes to effectuate Fas- and perforin-mediated cytotoxicity was investigated. Spleen and lymph nodes cells spontaneously lyse Fas+ targets (thymocytes) through a Fas-mediated mechanism as a consequence of their overex-pression of Fas ligand (FasL) confirmed by semiquantitative reverse transcription (RT)-PCR and immunoprecipitation analysis. This cytotoxicity was greatly increased after stimulation of the effectors by phorbol myristate acetate (PMA)+ionomycin. Under these conditions, MRL/lpr spleen and LN cells exhibited strong Fas-mediated Ca2+-independent cytotoxic activity against wild-type Fas+ (H-2 compatible or incompatible) thymocytes or lipopolysaccharide (LPS)-transformed blast cells. Such Fas-mediated cytotoxic activity was also observed with C57BL/6-lpr, but never with wild-type C57BL/6 or MLR+/+ effectors. Depletion experiments showed that the effector cells of this Fas-mediated cytotoxicity were DN T cells. This subset, which represent in vivo activated T cells, can spontaneously lyse Fas+ targets by a mechanism that does not need the interaction of the T cell receptor (TCR) with major histocompatibility complex molecule plus antigen. This lytic potential is increased by PMA+ionomycin, which sends a second activation signal to these primed T cells. Therefore, the small amounts of Fas receptor expressed on MRL/lpr tissues may account for their nonspecific autoimmune attack by DN cells. In Con A-containing medium, which allows detection of the perforin-mediated pathway against Fas− targets, cytotoxic CD8+ effectors were detected that are able to kill lpr thymocytes via a Ca2+-dependent pathway. Thus, in MRL/lpr mice, these CD8+ cells could constitute potent cytotoxic effectors against cells presenting antigen to their TCR.Keywords
This publication has 33 references indexed in Scilit:
- Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liverNature Genetics, 1995
- The APO‐1/Fas (CD95) receptor is expressed in homozygous MRL/lpr miceEuropean Journal of Immunology, 1994
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway?European Journal of Immunology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Transcriptional Repression and Differential Splicing of Fas m-RNA by Early Transposon (ETn) Insertion in Autoimmune LPR MiceBiochemical and Biophysical Research Communications, 1993
- Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.The Journal of Experimental Medicine, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991
- Association of lpr gene with graft-vs.-host disease-like syndrome.The Journal of Experimental Medicine, 1985